Acelity, based in San Antonio, Texas, is releasing the PREVENA DUO Incision Management System, a disposable negative pressure wound therapy (NPWT) system that can be used to manage two surgical incisions at the same time. The company expects the PREVENA DUO to be used post vascular harvesting, breast reconstruction, and ortho trauma procedures that often result in more than one incision.
Negative pressure wound therapy has been shown effective to treat a variety of wound types and many practices have been adopting it as a regular part of post-op rehab to prevent infections and speed up healing of wounds.
PREVENA, the single site treatment device, has had extensive use already. Here’s some info from Acelity regarding the studies of the PREVENA:
Clinical studies have demonstrated the efficacy of PREVENA™ Incision Management System in significantly reducing the incidence rate of infections. According to one study led by Tim Matatov, M.D., Louisiana State University Health Sciences Center, evaluating the PREVENA™ Incision Management System in reducing the risk of groin wound infection after vascular surgery, PREVENA™ Therapy was found to reduce the incidence of groin wound infection compared to traditional skin adhesive or absorbent dressings (6 percent incidence of infection with PREVENA™ Therapy compared to 30 percent with control group). As groin incisions are prone to complications and the incidence of groin SSIs after vascular surgery can be as high as 44 percent, prevention is a key component of improving patient care. The results also indicated significant cost savings with the PREVENA™ Incision Management System. In fact, the study authors concluded that the cost of the PREVENA™ System was quickly exceeded by the traditional dressings group due to long hospitalization required for two patients with Szilagyi Grade III infections ($25,740 vs. > $45,000 respectively).